Adult Eczema Research Study (65 Weeks)

Adults aged 18 years or older with chronic eczema (atopic dermatitis), may qualify to participate. Individuals must have moderate to severe disease, with an onset of symptoms at least 2 years prior to study start. An inadequate response to treatment with topical medications, or for whom topical treatments are otherwise medically inadvisable, is also required.

Participants will receive investigational medication via injection (active study drug) or placebo during the initial treatment period. During the second treatment period, those individuals who previously received placebo will receive active study drug. Use of an emollient throughout the duration of the study is required. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will be provided.

Study participation will last about 65 weeks and involve about 11 visits to the study centre, plus a follow-up phone call.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more